Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Federal Trade Commission

Generated: January 21, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: sitagliptin phosphate

« Back to Dashboard

sitagliptin phosphate Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Watson Labs Inc sitagliptin phosphate; metformin hydrochloride 202365 50MG;500MG TABLET;ORAL
Apotex Inc sitagliptin phosphate 202425 100MG TABLET; ORAL
Teva Pharms Usa Inc sitagliptin phosphate;metformin hydrochloride 204591 50MG;1000MG TABLET, EXTENDED RELEASE;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.